Harjeet Singh

4PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 06, 2025
Collagen-disrupting attIL12 TIL therapy boosts deep T cell infiltration via dual signaling activation and CCKAR reduction in sarcomas.

Jiemiao Hu, Harjeet Singh, Yining Jin

|May 22, 2024
Author Correction: Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling.

Ali Rezvan, Gabrielle Romain, Mohsen Fathi

|May 15, 2024
Identification of a clinically efficacious CAR T cell subset in diffuse large B cell lymphoma by dynamic multidimensional single-cell profiling.

Ali Rezvan, Gabrielle Romain, Mohsen Fathi

|Apr 09, 2021
Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia.

Francesco Paolo Tambaro, Harjeet Singh, Emily Jones

Pageof 1

Frequent Collaborators

2 joint publications

Xingyue An

2 joint publications

Nahum Puebla-Osorio

2 joint publications

Sattva Neelapu

2 joint publications

Navin Varadarajan